{
    "clinical_study": {
        "@rank": "14861", 
        "arm_group": [
            {
                "arm_group_label": "Supplemental oxygen", 
                "arm_group_type": "Experimental", 
                "description": "Patients are supposed to use ambulatory supplemental oxygen during physical activity. The intervention will last for six months.\nIn addition to supplemental oxygen the patients will be stimulated by a physiotherapist to be more physically active. A behavioural medicine intervention will be used."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "The control group will not get supplemental oxygen during physical activity but they will get the same physical activity intervention as the intervention group."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this trial is to study the effects on exercise capacity, physical activity,\n      inflammatory markers and quality of life of supplemental ambulatory oxygen, to be used\n      during physical activity, in patients with COPD who are normoxic at rest but hypoxemic\n      during a six-min walk test.\n\n      Our hypothesis is that if patients are able to use supplemental oxygen they will be more\n      physically active and thereby improve health related quality of life."
        }, 
        "brief_title": "Intervention Study to Investigate Supplemental Oxygen in COPD", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "COPD", 
            "Physical Activity", 
            "Sedentary"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study design The study will employ a parallel design for 6 months including 144 patients (72\n      patients/group). Patients will be randomized to intervention or control group. The\n      intervention comprises supplemental oxygen to be used during physical activity for 6 months.\n      The control group will receive the same physical activity instructions as the intervention\n      group during the 6 months, but they will not be able to use supplemental oxygen during\n      physical activity.\n\n      The study will be a prospective, randomized, single-blind multi-centre intervention study\n      with an intention to treat design (last value carry over). Inclusion will continue until 144\n      patients have fulfilled the 6 months. Patients will be tested at baseline and after 6\n      months. There will also be a follow-up after 12 months comprising questionnaires. The study\n      will include centers in Sweden Norway, Finland, and Estonia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  COPD, Arterial Oxygen Saturation > 8 kilopascal at rest\n\n          -  Oxygen Saturation  \u2264 88% and a fall in Oxygen Saturation  \u2265 4% during a six-minute\n             walk test in ambient air\n\n          -  No exacerbation within 4 weeks prior to the study\n\n          -  Post-bronchodilator forced expiratory volume at one second < 80% predicted and forced\n             expiratory volume at one second /Vital capacity < 0.7\n\n          -  Oxygen Saturation   \u2265 92 % during a walk test in self-selected pace with supplemental\n             oxygen.  Patients should use supplemental oxygen 10 minutes before the test starts.\n\n          -  Non-smoker (smoke free for \u2265 6 months)\n\n          -  Interest  in being physically active\n\n        Exclusion Criteria:\n\n          -  Arterial carbon dioxide > 6.5 kilopascal at rest\n\n          -  Orthopedic, neurologic or mental impairments that would limit physical activity\n\n          -  Neoplastic disease that is anticipated to influence survival\n\n          -  Patients exercising with supplemental oxygen\n\n          -  Long-term oxygen therapy\n\n          -  Patients with arterial auricular fibrillation and/or heart disease that might hinder\n             physical activity as judged by the physician"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "144", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783808", 
            "org_study_id": "Ambox-2012-MEUP", 
            "secondary_id": "Uppsala University"
        }, 
        "intervention": {
            "arm_group_label": "Supplemental oxygen", 
            "description": "Patients are supposed to use ambulatory supplemental oxygen during physical activity. The intervention will last for six months.\nIn addition to supplemental oxygen the patients will be stimulated by a physiotherapist to be more physically active. A behavioural medicine intervention will be used.", 
            "intervention_name": "Supplemental oxygen", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "Physical capacity", 
            "Physical activity", 
            "Inflammatory markers", 
            "Health related quality of life"
        ], 
        "lastchanged_date": "February 1, 2013", 
        "location": {
            "contact": {
                "email": "margareta.emtner@neuro.uu.se", 
                "last_name": "Margareta I Emtner, PhD", 
                "phone": "+46184714761"
            }, 
            "contact_backup": {
                "email": "christer.janson@medsci.uu.se", 
                "last_name": "Christer Janson, Professor", 
                "phone": "+46186114115"
            }, 
            "facility": {
                "address": {
                    "city": "Uppsala", 
                    "country": "Sweden", 
                    "zip": "751 85"
                }, 
                "name": "Akademiska sjukhuset"
            }, 
            "investigator": {
                "last_name": "Margareta I Emtner, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects on Exercise Capacity, Physical Activity and Quality of Life Using Ambulatory Oxygen in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Desaturate Only During Exercise", 
        "other_outcome": [
            {
                "description": "EuroQol five-dimension questionnaire, St Georges Respiratory Questionnaire, Hospital Anxiety and Depression Scale, COPD Assessment Test, Medical Research Council scale", 
                "measure": "Health related quality of life", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to six months"
            }, 
            {
                "description": "C-reactive protein, Leucocytes, Thrombocytes, Erythrocytes, Hemoglobin", 
                "measure": "Inflammatory markers", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 6 months"
            }
        ], 
        "overall_contact": {
            "email": "margareta.emtner@neuro.uu.se", 
            "last_name": "Margareta I Emtner, PhD", 
            "phone": "+46184714761"
        }, 
        "overall_contact_backup": {
            "email": "karin.wadell@physiother.umu.se", 
            "last_name": "Karin Wadell, PhD", 
            "phone": "+4690786 9887"
        }, 
        "overall_official": {
            "affiliation": "Department of Medical Sciences, Uppsala University", 
            "last_name": "Christer Janson, Professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Swedish National Council on Medical Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The patient is supposed to walk as long as possible during six minutes.", 
            "measure": "Six-minute walk test", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783808"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Uppsala University", 
            "investigator_full_name": "Margareta Emtner", 
            "investigator_title": "PhD, Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Physical activity will be measured with an activity monitor (accelerometer) and by a questionnaire", 
            "measure": "Physical activity level", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 6 months"
        }, 
        "source": "Uppsala University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ume\u00e5 University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Karolinska Institutet", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, Los Angeles", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Uppsala University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}